aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia

C A Thrash-Bingham1, K D Tartof

  • 1Fox Chase Cancer Center, Philadelphia, PA, USA.

Abstract

Insights

A novel natural antisense transcript, aHIF, is overexpressed in nonpapillary renal carcinoma, unlike papillary types. This discovery marks the first antisense transcript exclusively linked to a specific human cancer.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • Nonpapillary renal carcinoma is a distinct subtype of kidney cancer.
  • Hypoxia-inducible factor alpha (HIF1alpha) plays crucial roles in cellular responses to oxygen levels.
  • A natural antisense transcript, aHIF, complementary to HIF1alpha mRNA, was identified.

Purpose of the Study:

  • To characterize the natural antisense transcript aHIF.
  • To investigate the expression of aHIF in different types of renal carcinoma.
  • To understand the relationship between aHIF, HIF1alpha, and cellular conditions.

Main Methods:

  • Differential display
  • Reverse transcription-polymerase chain reaction (RT-PCR)
  • Ribonuclease protection assay
  • DNA sequencing

Main Results:

  • aHIF is a natural antisense transcript derived from HIF1alpha gene sequences.
  • aHIF is specifically overexpressed in nonpapillary clear-cell renal carcinomas but not in papillary renal carcinomas.
  • aHIF is overexpressed in nonpapillary renal carcinoma cells under both normoxic and hypoxic conditions.
  • Hypoxia induces aHIF in lymphocytes, with a concurrent decrease in HIF1alpha mRNA.

Conclusions:

  • This study reports the first natural antisense transcript exclusively overexpressed in a specific human malignancy.
  • aHIF represents a potential diagnostic marker for nonpapillary renal carcinoma.
  • The findings provide new insights into the molecular mechanisms of nonpapillary renal carcinoma development.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...